MENU
ACTU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Actuate Therapeutics (ACTU) Earnings Date & Reports
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3)... Show more
A.I. Advisor
published Earnings
ACTU is expected to report earnings to fall 10.00% to -18 cents per share on November 12
Q3'26
Est.
$-0.18
Q2'26
Beat
by $0.13
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.01
Q3'25
Missed
by $0.07
The last earnings report on August 14 showed earnings per share of -20 cents, beating the estimate of -33 cents. With 67.13K shares outstanding, the current market capitalization sits at 7.90M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
1751 River Run
Phone
+1 817 887-8455
Employees
12
Web
https://www.actuatetherapeutics.com